Oct 27, 2021 08:00 AM

Zhejiang Jolly Pharmaceutical Co.,Ltd.’s Net Profit Rose 113.6% in First Three Quarters of 2021

Zhejiang Jolly Pharmaceutical Co.,Ltd. (浙江佐力药业股份有限公司) (300181.SZ) reported a net profit of 141 million yuan in the first three quarters of 2021, up 113.6% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 40.1% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 899 million yuan in total liabilities, with a liability-to-asset ratio of 27.1%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin-Sinica Business Brief: China Resumes Issuing Visas to Foreigners